Genetic Lifespan launches AgeCode Report 2.0

Genetic Lifespan has launched AgeCode Report 2.0, a redesigned longevity platform that combines genetic and epigenetic data with AI to deliver more actionable health insights. The update is available now and adds expanded analysis, a new digital report, and better tools for tracking biological changes over time.

Why it matters: - AgeCode Report 2.0 is designed to move beyond a single biological age score and give customers and clinicians more usable guidance. - The update is meant to help users understand long-term health risks and track biological changes over time. - The company is positioning AgeCode as an AI-powered longevity platform, not just another biological age test.

What happened: - Genetic Lifespan announced the launch of AgeCode Report 2.0 on July 23, 2026. - The release applies to AgeCode Premier, the company’s longevity platform that combines epigenetic testing and genetic predisposition data. - All AgeCode customers will receive the new report upgrade. - AgeCode Report 2.0 is available now.

The details: - The updated reporting engine expands genetic analysis across additional SNPs and genes. - The Genetic Predisposition section has been redesigned. - The platform now includes enhanced data infrastructure to improve traceability. - The new system is built to support future longitudinal insights so customers can track biological changes over time. - Test results processed on or after July 1, 2026 include a new interactive digital report. - The updated report adds easier navigation between sections. - The mobile experience is faster and more responsive. - PDF downloads are now simplified through a single printer-icon export. - AgeCode reports combine genetics, epigenetics, methylation, and intracellular micronutrient data with actionable recommendations. - The reports often run well over 100 pages. - Genetic Lifespan’s broader ecosystem includes genetics, epigenetics, cardiovascular intelligence, biological age assessment, preventative health technologies, and data-driven wellness strategies. - The company says its platform is built to support healthier aging, improved performance, and informed decision-making.

Between the lines: - Genetic Lifespan is leaning into personalization and interpretability as differentiators in the crowded wellness-testing market. - The upgraded infrastructure suggests the company is preparing for more data over time, not just one-time test snapshots. - Founder and CEO Adam Vincent Gilmer said the redesign is meant to give people clarity and results they can act on.

What's next: - Customers and healthcare professionals using AgeCode are being encouraged to describe it as an AI-powered longevity platform rather than a standalone biological age test. - The improved traceability and longitudinal framework point to future reports that could show health changes over time. - Genetic Lifespan will likely keep building on the new digital report experience as it expands the platform.